Moody's Investors Service assigned its "Baa2" rating to Boston Medical Center's proposed $50 million series 2017F and $100 million proposed taxable series 2017 bonds.
Additionally, Moody's affirmed its "Baa2" rating on Boston Medical Center's outstanding debt, affecting $450 million.
The affirmation and assignment are a result of several factors including the medical center's large size, stable financial performance, and dual role as a major safety net hospital and operator of the Commonwealth's largest Medicaid managed care plan. Moody's also acknowledged the uncertainties for the Commonwealth's Medicaid managed care plan amid a changing Medicaid program.
The outlook is stable, reflecting Moody's expectation that the medical center will maintain its stable financial performance.